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1. Introduction
Mycoplasma bovis was ﬁrst isolated in 1961 in the
United States (Hale et al., 1962). This wall-less bacterium
belongs to the class of the Mollicutes and causes bovine
mycoplasmosis, an infection that leads to a variety of
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A B S T R A C T
Bovine mycoplasmosis due toMycoplasma bovis causes several important bovine diseases
such as pneumonia, mastitis, arthritis, otitis, genital disorders or keratoconjunctivitis.
Variable surface lipoproteins, adhesion, invasion of host cells, modulation of the host
immune system, bioﬁlm formation and the release of secondarymetabolites like hydrogen
peroxide, as well as synergistic infections with other bacterial or viral pathogens are
among the more signiﬁcantly studied characteristics of the bacterium.
The aim of this review is to summarize the current knowledge regarding the virulence
of M. bovis and additionally, factors contributing to the dissemination and persistence of
this pathogen in the bovine host will be discussed.
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clinical manifestations, mostly of chronic nature, including
bronchopneumonia (Caswell and Archambault, 2007;
Gagea et al., 2006), otitis (Maeda et al., 2003), mastitis
(Jasper, 1994), genital disorders (Doig, 1981; Hermeyer
et al., 2012b), arthritis (Gagea et al., 2006), meningitis
(Ayling et al., 2005) or keratoconjunctivitis (Alberti et al.,
2006). M. bovis can affect a large variety of tissues and
organs and is also isolated from healthy cattle. This
bacterium is considered to be one of the major emerging
pathogens of cattle in industrialized countries threatening
livestock production (Nicholas, 2011). To date, there is no
effective vaccine to prevent M. bovis infections (Mulongo
et al., 2013), therapy with antibiotics is scarcely efﬁcient
and increasing antimicrobial resistance is reported (Gau-
tier-Bouchardon et al., 2014).
Currently, there is limited understanding of the
molecular mechanisms of pathogenicity of mycoplasmas
and they appear to be multifactorial. Pathogenic Myco-
plasma species, in contrast to other bacteria, do not
distinguish themselves by the production of potent toxins,
with few exceptions like an ADP-ribosyl-transferase
described in Mycoplasma pneumoniae (Kannan and Base-
man, 2006).
Until recently, the lack of genetic tools and limited
research techniques hampered efforts to investigate the
pathogenesis and virulence factors of M. bovis, which is
essential to develop therapeutic and prophylactic mea-
sures to combat bovine mycoplasmosis. Random transpo-
son mutagenesis was recently used to generate mutants of
M. bovis (Chopra-Dewasthaly et al., 2005; Sharma et al.,
2012) and a new plasmid, replicating extrachromosomally
in M. bovis, was published (Li et al., 2014). With the
availability and further improvement of these techniques,
it should be possible to obtain detailed information about
the interactions ofM. boviswith its host in the near future.
This review presents an overview of the current
knowledge about the pathogenic mechanisms of M. bovis.
The following aspects are discussed: (1) co-infections with
other bacterial or viral organisms, (2) antigenic variation,
(3) adhesion, (4) bovine cells invasion, (5) modulation of
the host immune system and (6) secondary metabolites
and bioﬁlm formation.
2. Interactions with other microorganisms
In naturally infected cattle,M. bovis is often detected in
association with other microorganisms leading to the
hypothesis that synergism could be involved in the severe
lung lesions observed in necropsy material (Booker et al.,
1999, 2008; Martin et al., 1989; Shahriar et al., 2002). The
most common identiﬁed microorganisms in association
with M. bovis are Pasteurella multocida, Mannheimia
haemolytica,Histophilus somni, bovine respiratory syncytial
virus (BRSV), bovine herpes virus 1 (BHV-1), bovine viral
diarrhea virus (BVDV) and parainﬂuenza virus type 3 but as
described below some studies resulted in contradictory
ﬁndings (Booker et al., 1999, 2008; Martin et al., 1989;
Shahriar et al., 2002).
Natural infection with M. bovis can result in exudative
bronchopneumonia with occasional extensive foci of
coagulative necrosis, whereas experimental infections
lead to subclinical pneumonia and less severe lung lesions
(Rodriguez et al., 1996). Hence, severe pulmonary disease
symptoms caused by M. bovis are suspected to be the
consequence of synergistic interactions between myco-
plasmas and other microorganisms causing signiﬁcant
issues for farm management. Additionally, the age and the
immune status of individual animals are probably also
important for the development of disease, asM. bovis alone
was described to be able to cause pneumonia in very young
calves, while synergistic viral or bacterial infections may
be necessary to cause the typical extensive caseonecrotic
lesions in the lungs of adult animals in feedlots (Hermeyer
et al., 2012a; Prysliak et al., 2011).
More speciﬁcally, M. bovis seems to interplay with the
bacterial pathogens H. somni, M. haemolytica and P.
multocida. This was shown in experimentally induced
bovine respiratory disease where M. bovis acted as a
predisposing factor for severe symptoms in calves after
secondary infection with P. multocida (Gourlay and
Houghton, 1985). Other investigations considered an onset
of M. bovis-mediated symptoms in tissue pre-damaged
through lesions caused by P. multocida,M. haemolytica orH.
somni. In these cases, M. bovis was supposed to withstand
the curing of primary infections caused by the Pasteur-
ellaceae by antibiotics or by the host immune system
(Gagea et al., 2006). In another study, a signiﬁcant
association of H. somni and M. bovis was detected in
feedlot calves, where 80% of H. somni cases were positive
for M. bovis, whereas no signiﬁcant association was seen
between M. bovis and BVDV or M. haemolytica (Booker
et al., 2008).
Co-infections with BVDV were shown to result in more
severe respiratory disease in cattle through the immuno-
suppressive effects of the virus (Martin et al., 1990;
Potgieter, 1995). However, in feedlot cattle contradictory
data are available regarding the association between M.
bovis and BVDV (Booker et al., 2008; Gagea et al., 2006;
Prysliak et al., 2011; Shahriar et al., 2002). Concerning co-
infection of M. bovis with BRSV, no signiﬁcant increase in
the severity of clinical signs was detected when compared
to single infections with M. bovis (Thomas et al., 1986).
Interestingly, experimental co-infection with BHV-1 and
M. boviswere performed to induce classicalM. bovis lesions
in organs (Prysliak et al., 2011). Indeed, co-infection of 6–
8-month-old feedlot calves resulted in caseonecrotic
bronchopneumonia typical of M. bovis infection, while
infection with M. bovis alone caused only small consolida-
tions in the lung. Moreover the mortality rate was high,
revealing the severe synergistic effect of this co-infection
between M. bovis and BHV-1 (Prysliak et al., 2011).
3. Antigenic variation
Highly variable antigenic proﬁles ofM. bovis, which are
strain independent, have been observed (Poumarat et al.,
1994). This ﬁnding suggested that high frequency phase
(ON–OFF) and size variation of membrane surface lipo-
proteins occur as have been demonstrated for several other
Mycoplasma species (Razin et al., 1998). The antigenic
heterogeneity of M. bovis strains is unrelated to the
geographical origin, organ of isolation or type of disease
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induced by single strains but is variable among different
subclones of the same strain. This variability was shown to
be based on several prominent amphiphilic, integral,
membrane proteins, containing cross-reactive epitopes
acting as major immunogens (Rosengarten et al., 1994).
High frequency antigenic switching was demonstrated to
be affected by the presence of cognate M. bovis antibodies
in vitro (Le Grand et al., 1996). These points supported
previous assumptions indicating that this system serves as
a successful strategy to maintain diversity in strain
subpopulations allowing M. bovis to evade the host
immune system. Thereby, the host’s attempts to eliminate
this bacterium aremassively compromised contributing to
the chronic manifestation of diseases caused by M. bovis
(Buchenau et al., 2010).
Antigenic proﬁles of subclones of M. bovis type strain
PG45 revealed highly dynamic variations at the level of
expression and molecular masses of the antigens (Rosen-
garten et al., 1994). These antigens were shown to belong
to a family of phase and size variant variable membrane
surface lipoproteins (Vsps). In the type strain PG45, this
family comprises 13 different, single-copy vsp genes,
organized in a chromosomal cluster, the vsp-locus. This
locus of approximately 23 kb contains two additional ORFs
with high homology to the mobile genetic elements IS4
and IS30. ORFs encoding vspA, vspB, vspC, vspE, vspF, vspG,
vpsH, vspI, vspJ, vspK, vspL, vspM, vspN and vspO (Fig. 1)
were identiﬁed as well as their deduced proteins, VspA,
VspB, VspC, VspE, VspF, VspG, VspH, VspI, VspJ, VspK, VspL,
VspM, VspN, and VspO (Behrens et al., 1994; Lysnyansky
et al., 1996, 1999). The members of the vsp-locus were
designated as putative lipoproteins, having amphiphilic
characteristics as well as fatty acids and cysteine-residues.
The vsp genes were shown to contain a conserved 50
noncoding sequence, divided in 2 cassettes, the ﬁrst one
(cassette I) is 99% homologous in all vsp genes and encodes
a putative ribosomal binding site and the second one
(cassette II), located upstreamof cassette I, ismore variable
(Fig. 2) (Lysnyansky et al., 1999). This sequence is followed
by an open reading frame with an N-terminal region
exhibiting 98–99% identity among strains and encom-
passing a prolipoprotein signal peptide (Fig. 2) (Lys-
nyansky et al., 1999; Nussbaum et al., 2002), while the C-
terminal domain of Vsps is surface-exposed (Behrens et al.,
1994; Lysnyansky et al., 1996, 1999; Rosengarten et al.,
1994).
The co-expression of several Vsps leads to M. bovis
surface mosaics with different speciﬁc structural and
antigenic features. Co-expression of vsp genes was
observed to be restricted to two genes per isolate, while
the rest of the vsp genes remain transcriptionally silent
(Lysnyansky et al., 1999). It has to be noted that an
intergenic recombination event between vspA and vspO
results in vspC (Lysnyansky et al., 2001a) explaining the
absence of co-expression of the vspA and vspC genes, the
lack of vspC in strains expressing the vspA and vspB genes
and the structural similarity between VspA and VspC
proteins (Lysnyansky et al., 1999). The production of the
chimeric product vspC with the highly conserved ﬁrst
cassette (cassette I) of the N-terminus acquired from vspO
and the second cassette (cassette II) as well as the variable
C-terminus obtained from vspA further increases the
possibilities of antigenic variation, since vspC is also
capable of phase and size variations. There is, however,
a loss of genetic information in VspC expressing isolates
since vspA, vspM, vspN and vspO are deleted. Therefore, the
in vivo survival of VspC variants harboring the truncated
vsp-locus is questionable (Lysnyansky et al., 2001a).
Antigenic variability includes shifts of banding pat-
terns through insertions and deletions in speciﬁc repeti-
tive blocks (high-frequency size variation) resulting in 10-
, 9-, and 5-different size variants for VspA, VspB and VspC,
respectively (Behrens et al., 1994). Eighteen diverse
repetitive blocks were discovered among all vsp genes
of strain PG45, extending from their N-, to their C-
terminus, differing in size and amino acid structure. Some
of these blocks are present in only one gene, while others
exist in several distinct Vsps and are arranged as tandem
domains varying in repetitions and encompassing up to
80% of the protein (Fig. 2) (Lysnyansky et al., 1999). These
repetitive sequences together with the speciﬁc vsp
inversion sequences (vis) within the highly conserved
cassette I (Fig. 2) are perfect targets for recombination
events leading to duplications, inversions or deletions of
those domains (Lysnyansky et al., 1996, 2001a). Further-
more, highly conserved cassettes II serve as general active
promoters for several Vsps and regulate the expression of
genes situated downstream (Fig. 2) (Lysnyansky et al.,
2001b). High-frequency phase variation in antigen
expression results in gain or loss of surface antigens
due to chromosomal recombination events (Behrens et al.,
1994). These events occur in vitro at a frequency of 102 to
103 per cell per generation (Lysnyansky et al., 1996). At
the genetic level, rearrangements were visualized
through HindIII-digestion of chromosomal DNA and
resulted in different lengths of fragments comparing
VspA and VspC ON and OFF variants respectively
(Lysnyansky et al., 1996, 2001b).
[(Fig._1)TD$FIG]
Fig. 1. vsp-locus ofM. bovis type strain PG45. Image produced using SnapGene1 Viewer 2.3.2 Software from the publishedwhole genome sequence of strain
PG45 (CP002188.1; phenotype VspO ON) (sequence published by Wise et al. (2011)).
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Variation in expression and size of Vsps was demon-
strated in vivo in the respiratory tract of experimentally
infected calves (Buchenau et al., 2010). Moreover, Vsps
were shown to be expressed in 98.5% of 250 M. bovis ﬁeld
isolates tested using the monoclonal antibody 1E5, which
was suggested to bind to a repetitive domain present in the
VspA, VspB and VspC proteins (blocks shown in dark green
in Fig. 2) (Poumarat et al., 1999; Rosengarten et al., 1994).
The different genomic vsp patterns and phenotypic
Vsps antigenic proﬁles seem to be extremely complex
(Poumarat et al., 1999) although a study investigating
polymorphisms of vsp genes and the associated expression
proﬁles demonstrated a certain relatedness among ﬁeld
isolates sharing a common history (Beier et al., 1998).
Comparing type strain PG45 with M. bovis ﬁeld strains
reveals a massive variation in vsp reiterated sequences as
well as strain-speciﬁc repetitive sequences. This may
deﬁne the individual antigenic features of particular
strains, resulting in an extended vsp repertoire (Nussbaum
et al., 2002). Particular examples are M. bovis ﬁeld strain
2610 encoding a completely new member of the Vsp
family acting as an adhesin and the Chinese strain Hubei-1
expressing the variable surface lipoprotein A (VpmaX),
lacking the N-terminal protein region and upstream DNA
sequence conserved in PG45 but showing adhesion
properties (Thomas et al., 2005; Zou et al., 2013). The
difference in the number of vsp genes in the vsp-loci of
PG45 (13 vsp-related ORFs) and of the Chinese strain
HB0801 (6 vsp-related ORFs) is striking, despite the
conserved structure of the N-, and C-termini (Qi et al.,
2012). This high variation in vsp genes and consequently in
their repetitive units may arise from different selective
pressures from the host on individual strains and therefore
increases the number of possible variations in theM. bovis
population (Nussbaum et al., 2002).
4. Adhesion
Adhesion is one of the ﬁrst steps during mycoplasma
infection (Rottem, 2003). Therefore adhesins expressed on
the mycoplasmal membrane are of great importance
because of their direct contact with host cells (Sachse
et al., 1996). The intimate contact of mycoplasmas with
host cells is crucial for mycoplasmal survival. Because of
their small genomes, mycoplasmas lack a battery of genes
involved in essential biosynthetic pathways and have to
acquire essential substances such as amino acids, nucleo-
tides and lipids from the host. For this purpose, a fusion
between the mycoplasmal and the host membranes was
proposed to allow the exchange of membrane and
intracellular components (Razin and Jacobs, 1992). Inter-
estingly, there is no evidence of the presence of a tip
organelle in M. bovis (Behrens et al., 1996) serving as a
structure for a polar accumulation of major adhesins as for
M. pneumoniae (Razin and Jacobs, 1992). Putative adhesins
ofM. bovis are probably spread over the surface in the form
ofmembrane proteins (Behrens et al., 1996; Rottem, 2003).
In in vitro assays, M. bovis strain PG45 adhesion to
embryonic bovine lung cells (EBL) was shown to be
temperature dependent with maximal adhesion at 37 8C.
The cell receptor binding capacity was limited with
saturation reached at a multiplicity of infection (MOI) of
225:1 in EBL cells (Sachse et al., 1996) and 100:1 in bovine
bronchial epithelial (BBE) cells (Thomas et al., 2003b).
Large variation in cytoadherence rates (3.4–19.1%)
were recorded among various M. bovis strains indepen-
dently from the organ of isolation but determined by the
type of host cells tested (Sachse et al., 1996; Thomas et al.,
2003a). Signiﬁcantly lower adherence was observed in less
or non-pathogenic strains compared to virulent strains
(Thomas et al., 2003a,b). Moreover, cytoadherence rates
were lower using a ﬁbroblast cell line and primary BBE
cells compared to rates in epithelial cell lines (Thomas
et al., 2003a,b). Additionally,M. bovis strains seem to loose
adherence ability after continuous in vitro passaging
(Thomas et al., 2003a,b).
M. bovis adhesion is driven by protein interactions since
trypsin treatment of M. bovis leads to a partial decrease in
adherence (Sachse et al., 1996; Thomas et al., 2003b).
Moreover, sialic acid residues in M. bovis proteins were
shown to play a role in cytoadhesion (Sachse et al., 1993,
1996).
At the level of speciﬁc proteins, the 32 kDa membrane
surface-exposed protein P26 was shown to be a major
adhesin of M. bovis in the EBL cell model (Sachse et al.,
1993, 1996). However, the monoclonal antibody 4F6
directed against P26 did not signiﬁcantly reduce adhesion
to BBE cells (Thomas et al., 2003b). Another adhesion-
related factor of M. bovis is the membrane-associated
glycolytic enzyme a-enolase, since it induces mycoplas-
ma-adherence to EBL cells by binding plasminogen (Song
et al., 2012). In fact, pretreating EBL cells with plasminogen
augmented M. bovis adhesion by 11.9% (Song et al., 2012).
Pre-treatment of M. bovis with low concentrations of
trypsin increased their proteolytic activity and adhesion
rate to EBL cells, indicating that other proteolytic enzymes
activated by partial digestion with minimal amounts of
trypsin are also involved in adhesion (Song et al., 2012).
Vsps were also shown to play a role in M. bovis cell
adhesion (Sachse et al., 1996) since host cells bound Vsps in
Western blots (Sachse et al., 1996). Moreover, addition of
puriﬁed Vsps decreased M. bovis cytoadhesion and Vsps
were retained on host cell layers during cell adhesion
[(Fig._2)TD$FIG]
Fig. 2. Simpliﬁed structural features of the vspA vspB and vspO genes ofM.
bovis type strain PG45. The white block (P) represents a highly conserved
150 bp non-coding 50 region upstream from the ATG codon, divided in
2 cassettes. The ﬁrst (cassette I), includes the putative ribosomal binding
site, whereas the second (cassette II) is a general active promoter in
vspA. The 75 bp highly homologous DNA sequence coding for the vsp signal
peptide is displayed by thegray block (S), followedby a thirdblock in black,
conserved in all vsp genes. Colored blocks indicate the reiterated coding
sequences, extending from the N- toward the C-terminus. Those repetitive
domains can be shared among different vsp genes (blue-, red-, and dark
green blocks) or are vsp-speciﬁc (bright green-, and yellow blocks).
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experiments (Sachse et al., 2000). This was evidenced
through the partial cytoadherence inhibition of M. bovis
PG45 toward EBL cells, using oligopeptides from repetitive
domains of Vsps (Sachse et al., 2000). The M. bovis speciﬁc
monoclonal antibodies 1E5 and 4D7 (both against common
epitopes in VspA, VspB and VspC), 2A8 (against VspC) and
9F1 (against VspF) were used to investigate if mycoplasmal
Vsps contact sites are accessible to antibodies. Results
showed a partial blocking of adherence of M. bovis strains
PG45 and 0435 by all speciﬁcmonoclonal antibodies due to
their binding to adherence sites of Vsps. However, the
inhibition of adherencewas dependent on the cell line used
(Sachse et al., 1996, 2000; Thomas et al., 2003b). Variationof
surface antigens through insertion or deletion of the
repetitive units in Vsps generates additional epitopes or
removes some epitopes, resulting in an increase or decrease
in cytoadhesion also leading to a wider or smaller range of
ligands to bind to (Sachse et al., 2000).
5. Cell invasion
In calves infected with M. bovis, mycoplasmas were
found in the cytoplasm of various cell types such as
macrophages, neutrophils, hepatocytes, bile duct epithelial
cells, renal tubular cells or axons of facial nerves. M. bovis
antigen was additionally detected in monocytes, lymph
nodes and also occasionally in bronchiolar epithelial cells
(Adegboye et al., 1995; Kleinschmidt et al., 2013; Maeda
et al., 2003; Rodriguez et al., 1996). The survival ofM. bovis
in phagocytes indicates intracellular persistence of the
bacteria presumably through an alteration of one of the
steps following engulfment during the process of phago-
cytosis (Kleinschmidt et al., 2013).
In an in vitro assay, M. bovis strain Mb1 was found to
persist in various bovine peripheral blood mononuclear
cells (PBMC) subpopulations such as T cells, T helper cells,
B cells, monocytes, gd T cells, cytotoxic T cells, natural
killer (NK) cells and dendritic cells, as well as in bovine
erythrocytes (van der Merwe et al., 2010). Dependent on
the cell type used and the time of infection, different
intracellular localizations of M. bovis were identiﬁed. M.
bovis associated with the cytosolic side of the cell
membrane, present in vacuole-like structures as well as
a diffuse distribution were observed. Different extent and
rate of invasion between cell types and PBMC subpopula-
tions may occur due to distinct receptors required for M.
bovis adhesion and invasion, or to differential signaling
induced byM. bovis reliant on the cell type (van derMerwe
et al., 2010).
Interestingly, M. bovis was not found inside alveolar
epithelial cells of the udder (Stanarius et al., 1981).
However, our recent in vitro investigations using ﬂuores-
cence and transmission electron microscopy conﬁrmed an
intracellular stage of virulent M. bovis in primary
embryonic calf turbinate cells (Fig. 3).
Overall, M. bovis invasion of epithelial cells, as well as
immune cells could contribute to the dissemination of the
pathogen to different infection sites in the host and impair
control of M. bovis infection through antibiotic treatment.
However, further investigations are necessary to dissect
the molecular mechanisms involved in persistence of M.
bovis in different bovine cell types.
6. Modulation of the host’s immune system
Mycoplasmal membrane proteins are important be-
cause of their direct interaction with the host immune
system. M. bovis–host cell interactions seem to be
dependent on the cell type, or the subset of PBMCs. Van
der Merwe and collaborators observed induction of IFN-g
[(Fig._3)TD$FIG]
Fig. 3. Differential ﬂuorescence microscopy image of primary embryonic calf turbinate cells infected with M. bovis strain JF4278 for 6 h, multiplicity of
infection (MOI) 3400:1. Cell nuclei appear in blue and F-actin in red. Panel A: Uninfected turbinate cells. Panel B: intracellularM. bovis are stained in green
and extracellular as well as cell-attached mycoplasmas are marked in dark yellow to orange. Merged images, 600 magniﬁcation.
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in T cells, T helper cells, cytotoxic T cells, NK cells and gd T
cells, whereas no IFN-g induction was measured in
monocytes, dendritic cells or B cells (van der Merwe
et al., 2010). Similarly, there are controversial studies
concerningM. bovis induced apoptosis of PBMCs (Mulongo
et al., 2014; Vanden Bush and Rosenbusch, 2002). Under in
vitro conditions, the induction of apoptosis in lymphocytes
by M. bovis was reported (Vanden Bush and Rosenbusch,
2002), whereas a delay of the apoptosis process in bovine
monocytes infected withM. boviswas observed in another
study (Mulongo et al., 2014). Moreover, there are reports
suggesting suppression as well as stimulation of the host
immune systembyM. bovis. Immune stimulation seems to
occur through macrophages, T cells, or complement
activation as well as by the expression of cytokines up-
regulating the immune response (Jungi et al., 1996; Kauf
et al., 2007; Razin et al., 1998; Robino et al., 2005; Rosati
et al., 1999; van der Merwe et al., 2010; Vanden Bush and
Rosenbusch, 2003). Immune suppression is suspected to
occur by the expression of anti-inﬂammatory cytokines or
chemokines like IL-10 and by the suppression of expres-
sion of pro-inﬂammatory cytokines such as IFN-g and
TNF-a (Mulongo et al., 2014). IL-10 then shifts the
adaptive immune response to [1_TD$DIFF]express T helper cells type
2 (Th2), resulting in strong expression of IgG1, leading to
poor opsonization and immunity. Alternatively, suppres-
sion of the host immune system could be accomplished by
the down-regulation of lymphocyte proliferation, by a
putative mycoplasmal lympho-inhibitory protein, or
through interference with the lympho-proliferative re-
sponse to phytoagglutinin (Thomas et al., 1990; van der
Merwe et al., 2010; Vanden Bush and Rosenbusch, 2003).
Thereby the proliferation of lymphocytes is down-
regulated, whereas their cytokine expression is not
altered. M. bovis seems to suppress the lymphocyte-
mediated immune response via a decrease of their
population (van der Merwe et al., 2010). Another strategy
ofM. bovis to restrain the host immune response is to bind
neutrophils and thereby inhibit their oxidative burst
(Thomas et al., 1991). Themodulation of the host immune
response is compatible with a prolonged survival and
systemic dissemination ofM. bovis in the host as observed
in infected cattle (Mulongo et al., 2014).
7. Bioﬁlm formation and secondary metabolites
Bioﬁlm production contributes to bacterial persistence
in the environment and inside the host leading to the
chronicity of a disease. Additionally, bioﬁlms can also
increase damage in host tissues since phagocytes are
attracted, releasing lysosomal enzymes, reactive oxygen,
and nitrogen species (ROS and RNS), whereas phagocytosis
is rather inefﬁcient under these conditions (Hermeyer
et al., 2011; McAuliffe et al., 2006). Several Mycoplasma
species including M. bovis produce bioﬁlms apparently
independently of their pathogenicity (McAuliffe et al.,
2006). The capacity of several Mycoplasma species to
adhere to host cells appears to be essential since adherence
to coverslips was observed as the initial step of bioﬁlm
formation (McAuliffe et al., 2006). The extent of bioﬁlm
formation under in vitro growth is very diverse among M.
bovis strains and correlates with the different molecular
types or Vsp proﬁles (McAuliffe et al., 2006). Since Vsps are
supposed to be involved in adhesion (Sachse et al., 1996,
2000), certain Vsp patterns may display different adhesion
capabilities, resulting in a variable ability to form bioﬁlms
(McAuliffe et al., 2006). Bioﬁlm production increases
bacterial resistance toward environmental stressors and
host defenses (Mah and O’Toole, 2001). Indeed, bioﬁlm
forming M. bovis strains were more resistant to heat and
desiccation enabling their survival in the environment,
whereas no change in minimal inhibitory concentrations
(MIC) of ﬂuoroquinolones and tetracyclines was detected
(McAuliffe et al., 2006).
Secondary metabolites were shown to be involved in
the pathogenesis of Mycoplasma sp. (Hames et al., 2009;
Pilo et al., 2005). Hydrogen peroxide (H2O2) production is
a major virulence factor of several Mycoplasma species,
leading to cell death, inhibition of ciliary action or
peroxidation of lipids (Hames et al., 2009; Pilo et al.,
2005; Tryon and Baseman, 1992). In necropsy material,
H2O2 production was identiﬁed in all M. bovis isolates
(Schott et al., 2013). Additionally, ROS and RNS were
detected following the recruitment and stimulation of
macrophages and neutrophils. The combination of myco-
plasmal H2O2 and ROS/RNS from white blood cells may
result in the severe typical caseonecrotic lung lesions
(Hermeyer et al., 2011; Schott et al., 2013). H2O2
formation by M. bovis type and ﬁeld strains was also
measured in vitro showing strain variability concerning
the amount ofH2O2 produced (Khan et al., 2005). Amounts
of H2O2 generated from NADH oxidation varied from 0 to
1.1mol H2O2/mol O2 depending on the strains. This is
proposed to be due to NADH-oxidase mainly producing
either water or H2O2 (Khan et al., 2005). In vitro passage of
strains led to a reduction of H2O2 levels, whereas
oxidation-rates of other substrates did not change. This
was demonstrated by the loss of a 32 kDa protein after
extensive passaging of aM. bovis strain in axenic medium
that correlated with a 50% reduction of H2O2 production
(Khan et al., 2005). However, L-a-glycerophosphate (GP)
was never oxidized by any strain tested, indicating the
absence of glycerophosphate oxidase (GlpO) in all non-
fermentative, non-arginine-hydrolyzing M. bovis strains
(Khan et al., 2005).
8. Conclusion
Among the multiple virulence attributes of M. bovis
described in this review, variable surface lipoproteins
have been intensively investigated. They play an impor-
tant role to circumvent the host immune recognition
system and in adaptive evolution, compensating for the
limited genome size ofMycoplasma species. Furthermore,
some of these surface antigens are involved in mycoplas-
ma adhesion to host cells, which is a requirement for the
establishment of infection. Other virulence attributes
were less studied but the advent of new molecular tools
should lead to a better understanding of the mechanisms
involved in the pathogenesis of this bacterium. Bioﬁlm
formation is likely to be essential for persistence of M.
bovis in the host and in its close environment. Moreover,
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host cell damage due to secreted metabolites of M. bovis
such as H2O2 deserves more investigation to understand
the molecular processes involved as well as the role of
co-infecting microorganisms and the modulation of the
host immune response. Finally, invasion and intracellular
survival of M. bovis in bovine cells could contribute to
the persistence and dissemination in the host and may
lead to the resistance of M. bovis infections to antibiotic
treatments and vaccination trials against bovine myco-
plasmosis.
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